rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John T. Curnutte

Director

Company insider

Files Form 4 as: Director, Pliant Therapeutics; Director, Orchard Therapeutics; EVP R&D, Portola Pharmaceuticals; Director, Diadexus.

Every Form 4 they filed

In numbers

Trades disclosed
103
Buys
0
Sells
14
Bought
$0
Sold
$8.9M
Companies
4
Companies where not an officer
3
First trade
26 Mar 2014
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
Portola PharmaceuticalsOfficer · last 20 May 20190 buys · 14 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PLRX Pliant TherapeuticsDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells
Orchard TherapeuticsDirector · last 24 Jan 20240 buys · 0 sells
DiadexusDirector · last 15 Jul 20150 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
11 Jun 2026filed 12 Jun 2026PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
5 Jun 2025filed 9 Jun 2025PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
13 Jun 2024filed 17 Jun 2024PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—26,764 at $0.00filing
24 Jan 2024filed 24 Jan 2024Orchard Therapeuticsoption or derivativeSEC FORM 4 Code D—46,000 at $0.00filing
24 Jan 2024filed 24 Jan 2024Orchard Therapeuticsoption or derivativeSEC FORM 4 Code D—105,000 at $0.00filing
14 Jun 2023filed 16 Jun 2023Orchard Therapeuticsoption or derivativeSEC FORM 4 Code A—105,000 at $0.00filing
7 Jun 2023filed 8 Jun 2023PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—14,000 at $0.00filing
16 Jun 2022filed 21 Jun 2022PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
7 Jun 2022filed 8 Jun 2022Orchard Therapeuticsoption or derivativeSEC FORM 4 Code A—46,000 at $0.00filing
29 Jun 2021filed 30 Jun 2021PLRX Pliant Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—13,286 at $0.00filing
16 Jun 2021filed 17 Jun 2021Orchard Therapeuticsoption or derivativeSEC FORM 4 Code A—40,000 at $0.00filing
17 Jun 2020filed 19 Jun 2020Orchard Therapeuticsoption or derivativeSEC FORM 4 Code A—35,000 at $0.00filing
20 May 2019filed 21 May 2019Portola PharmaceuticalsSEC FORM 4 Code F$69K2,418 at $28.69filing
20 May 2019filed 21 May 2019Portola PharmaceuticalsSEC FORM 4 Code F$26K903 at $28.69filing
17 May 2019filed 21 May 2019Portola Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—4,688 at $0.00filing
17 May 2019filed 21 May 2019Portola PharmaceuticalsSEC FORM 4 Code A—4,688 at $0.00filing
17 May 2019filed 21 May 2019Portola PharmaceuticalsSEC FORM 4 Code A—1,750 at $0.00filing
4 Mar 2019filed 5 Mar 2019Portola PharmaceuticalsSEC FORM 4 Code F$215K6,446 at $33.41filing
31 Jan 2019filed 4 Feb 2019Portola Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—18,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed14

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.